Search results

151. The significance of the serotonergic innervation of the brain hypothalamus in the regulation of cytochrome P450

Principal investigator: prof. Władysława Anna Daniel

Instytut Farmakologii PAN

Call: OPUS 6, Panel: NZ7

152. The influence of 5-HT7 and NMDA receptor ligands with possible antidepressive properties on the activity of rat dorsal r…

Principal investigator: prof. Grzegorz Władysław Hess

Instytut Farmakologii PAN

Call: OPUS 6, Panel: NZ4

153. Motor thalamic nuclei as a potential therapeutic target for adenosine in parkinsonian and essential tremor; behavioural,…

Principal investigator: dr hab. Jadwiga Wardas

Instytut Farmakologii PAN

Call: OPUS 6, Panel: NZ4

154. Effect of caffeine on neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse brain.

Principal investigator: Anna Maria Górska

Instytut Farmakologii PAN

Call: PRELUDIUM 6, Panel: NZ7

155. Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi…

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: HARMONIA 5, Panel: NZ4

156. "Legal Higsh"- CNS effects and neurotoxicity

Principal investigator: prof. Krystyna Czesława Gołembiowska

Instytut Farmakologii PAN

Call: OPUS 5, Panel: NZ7

157. Antidepressats as substances that increase the activity of risperidone, an atypical antipsychotic drug in animal models

Principal investigator: Katarzyna Karolina Kamińska

Instytut Farmakologii PAN

Call: PRELUDIUM 5, Panel: NZ7

158. Development of a tool for automatic evaluation of complexes of ligands with serotonin receptors based on the application…

Principal investigator: Sabina Marta Podlewska

Instytut Farmakologii PAN

Call: PRELUDIUM 5, Panel: NZ2

159. The role of chemokines in the pathogenesis of depression and molecular mechanism of action of antidepressants.

Principal investigator: prof. Agnieszka Basta-Kaim

Instytut Farmakologii PAN

Call: OPUS 5, Panel: NZ7

160. The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen…

Principal investigator: dr hab. Mariusz Papp

Instytut Farmakologii PAN

Call: OPUS 5, Panel: NZ7

161. Transcription factor MeCP2 as an intracellular object of study on the mechanism of depression and as a potential pharmac…

Principal investigator: dr Magdalena Jolanta Sowa-Kućma

Instytut Farmakologii PAN

Call: SONATA 5, Panel: NZ7

162. Molecular mechanism for the effects of stress hormones on development of drug addiction

Principal investigator: prof. Ryszard Przewłocki

Instytut Farmakologii PAN

Call: MAESTRO 4, Panel: NZ3

163. Involvement of 5-HT1A receptor signal pathway in the antidepressant effect of zinc

Principal investigator: dr Bernadeta Szewczyk

Instytut Farmakologii PAN

Call: HARMONIA 4, Panel: NZ7

164. Research on influence of antidepressant drugs on serum and brain levels of neurotrophins in rats, affected by the time d…

Principal investigator: dr Maciej Sławomir Kuśmider

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ4

165. The influence of glucagon-like peptied-1 receptor agaonists on regulation of coticotropin-releasing hormone gene promote…

Principal investigator: Jan Stanisław Detka

Instytut Farmakologii PAN

Call: PRELUDIUM 4, Panel: NZ7

166. The role of the brain serotonergic system in the expression and activity of liver cytochrome P450.

Principal investigator: dr Marta Anna Rysz

Instytut Farmakologii PAN

Call: PRELUDIUM 4, Panel: NZ7

167. Molecular markers of stress resilience in animal model of depression

Principal investigator: prof. Marta Dziedzicka-Wasylewska

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ7

168. The effects of positive allosteric modulators of alpha7 nicotinic acetylcholine receptors on complex cognitive processes…

Principal investigator: dr hab. Agnieszka Anna Nikiforuk

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ7

169. The effect of enriched environment on the epigenetic mechanism in neurodevelopmental model of schizophrenia.

Principal investigator: dr Ewelina Bator

Instytut Farmakologii PAN

Call: PRELUDIUM 4, Panel: NZ4

170. The research of molecular markers for neuroprotective effect of tetrahydroisoquinolines based on various eksperimental m…

Principal investigator: dr Agnieszka Wąsik

Instytut Farmakologii PAN

Call: OPUS 4, Panel: NZ7

171. Neurobiology of optimism; Characterisation of the neuroanatomical and neurochemical substrates of cognitive judgement bi…

Principal investigator: dr hab. Rafał Ryguła

Instytut Farmakologii PAN

Call: SONATA BIS 2, Panel: NZ4

172. Neural mechanisms underlying pathology of motivation.

Principal investigator: dr Jan Manuel Rodriguez-Parkitna

Instytut Farmakologii PAN

Call: SONATA BIS 2, Panel: NZ3

173. PHARMACOTHERAPY OF OSTEOARTHRITIS: TRPV1 AND CB1 RECEPTORS AND THEIR ENDOGENOUS LIGANDS AS NEW TARGETS FOR PHARMACOLOGIC…

Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Call: SONATA BIS 2, Panel: NZ7

174. Examine the importance of intracellular pathways in the action of opioids in microglial cells in vitro

Principal investigator: Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Call: PRELUDIUM 4, Panel: NZ3

175. The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

Principal investigator: dr Marta Ewa Kot

Instytut Farmakologii PAN

Call: SONATA 4, Panel: NZ4

176. Effects of restraint stress on properties of neurons and synaptic transmission in hypothalamic paraventricular nucleus o…

Principal investigator: Magdalena Joanna Kusek

Instytut Farmakologii PAN

Call: PRELUDIUM 4, Panel: NZ4

177. "Epigenetic mechanisms underlying cocaine seeking and relapse"

Principal investigator: prof. Małgorzata Maria Filip

Instytut Farmakologii PAN

Call: MAESTRO 3, Panel: NZ3

178. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

Principal investigator: prof. Andrzej Pilc

Instytut Farmakologii PAN

Call: MAESTRO 3, Panel: NZ7

179. Activation of endogenous pronociceptive mechanisms of opioid system as an important factors in the development of neurop…

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii PAN

Call: MAESTRO 3, Panel: NZ4

180. Plasticity of glutamatergic synapses on dopamine neurons: the mechanism of habit formation.

Principal investigator: dr hab. Jan Manuel Rodriguez-Parkitna

Instytut Farmakologii PAN

Call: HARMONIA 3, Panel: NZ4

181. Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the conte…

Principal investigator: dr Magdalena Anna Kolasa

Instytut Farmakologii PAN

Call: PRELUDIUM 3, Panel: NZ7

182. The study of the role of mGluR8 in cancer cells - a potential target for new antitumor strategies

Principal investigator: dr Danuta Jantas

Instytut Farmakologii PAN

Call: OPUS 3, Panel: NZ3

183. The role of CRH-BP protein in the regulation of the hypothalamic-pituitary-adrenal axis after antidepressant drugs treat…

Principal investigator: dr Joanna Solich

Instytut Farmakologii PAN

Call: OPUS 3, Panel: NZ4

184. Neurobiological basis of sensation seeking behaviour

Principal investigator: Magdalena Maria Sikora

Instytut Farmakologii PAN

Call: PRELUDIUM 3, Panel: NZ7

185. The role of astrocytes and cellular metabolism in functional compensation of degeneration of dopaminergic system in the …

Principal investigator: dr Katarzyna Kuter

Instytut Farmakologii PAN

Call: OPUS 3, Panel: NZ4

186. The role of glucocorticoids in the regulaton of neurodegenerative prosses

Principal investigator: Anna Jadwiga Kurek

Instytut Farmakologii PAN

Call: PRELUDIUM 3, Panel: NZ7

187. Probing the selectivity of zinc allosteric modulation in various serotonin receptor subtypes

Principal investigator: Grzegorz Marek Satała

Instytut Farmakologii PAN

Call: PRELUDIUM 3, Panel: NZ7

188. Define the role and modulation of immune diabetes changed factors - their importance to the action of analgesics.

Principal investigator: Magdalena Małgorzata Żychowska

Instytut Farmakologii PAN

Call: PRELUDIUM 3, Panel: NZ4

189. The influence of molecular fingerprint bit density on chemical pattern recognition effectiveness

Principal investigator: Rafał Jerzy Kurczab

Instytut Farmakologii PAN

Call: PRELUDIUM 2, Panel: NZ2

190. EFFECTS OF ADENOSINE A2A RECEPTOR LIGANDS ON BEHAVIORAL EFFECTS OF ABUSED DRUG (COCAINE) AND NATURAL REWARD (FOOD) USING…

Principal investigator: Karolina Agnieszka Wydra

Instytut Farmakologii PAN

Call: PRELUDIUM 2, Panel: NZ7

191. The role of the mGlu5-D2 heterodimeric receptor complexes in the extinction of drug seeking behavior associated with dep…

Principal investigator: dr Małgorzata Frankowska

Instytut Farmakologii PAN, Instytut Farmakologii Polskiej Akademii Nauk

Call: SONATA 2, Panel: NZ7

192. Glucocorticoid-induced alterations of astrocytic metabolism in stress-related disorders.

Principal investigator: dr Michał Wiesław Ślęzak

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ3

193. The molecular basis of stress-induced anxiety and affective disorders

Principal investigator: dr Michał Korostyński

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ2

194. Neuroplasticity regulation by alternative gene transcription

Principal investigator: dr Michał Korostyński

Instytut Farmakologii PAN

Call: SONATA 2, Panel: NZ3

195. Opioid receptors in the basal ganglia of the brain as targets for alcohol abuse therapy.

Principal investigator: dr Jan Manuel Rodriguez Parkitna

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ4

196. Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodege…

Principal investigator: dr Grzegorz Kreiner

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ7

197. Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi…

Principal investigator: dr hab. Joanna Gabriela Mika

Instytut Farmakologii PAN

Call: OPUS 2, Panel: NZ4

198. Impact of selective modulators of estrogen and aryl hydrocarbon receptors on hypoxia/ischemia-induced neuronal cell dama…

Principal investigator: Joanna Rzemieniec

Instytut Farmakologii PAN

Call: PRELUDIUM 1, Panel: NZ3

199. Impact of endocrine disrupting chemicals - 4,para nonylphenol - on toxic effects mediated by xenobiotic receptors PXR an…

Principal investigator: Ewa Joanna Litwa

Instytut Farmakologii PAN

Call: PRELUDIUM 1, Panel: NZ4

200. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

Principal investigator: dr hab. Jacek Wójcikowski

Instytut Farmakologii PAN

Call: OPUS 1, Panel: NZ4

Projects search